🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseNon-invasive MASH biomarkers — March 2026 Page 7

Non-invasive MASH biomarkers — March 2026

AttorneyGrant Thu, Feb 8, 2024 at 1:03 AM 54 replies 3,138 viewsPage 7 of 11
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Jun 28, 2024 at 5:31 PM#31
AttorneyGrant said:
The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

Same experience, arrived at from the opposite direction. Posting only so the count is not one.

Last edited: Jun 28, 2024 at 10:31 PM
4 2sarah_TO, wendy_avl, jason_paloalto and 1 other
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Jul 9, 2024 at 11:39 PM#32
AttorneyGrant said:
The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

Coming at AttorneyGrant’s question from a different direction. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

5 3tammy_FL, Dr.LipidDallas, alex_tucson and 2 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Jul 21, 2024 at 5:41 AM#33

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Jul 21, 2024 at 7:41 AM
6 4LibrarianMeg, bri_stats, pete_manc_UK and 3 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Aug 1, 2024 at 11:36 AM#34

Following on from AttorneyGrant — and this may be the naive question:

What would you measure differently if you were starting again?

Last edited: Aug 1, 2024 at 1:36 PM
7 5JenPlateau, SallyK_inj, CryptoCarl and 4 others
Reply Quote Save Share Report
JakeSmashed95
Member
412
1,890
Aug 2024
Arkansas
Online
Aug 12, 2024 at 5:25 PM#35
labquiet_amy said:
If you are going to change something, change one thing and give it long enough to express itself.

This is where I part company with the consensus forming above. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

Last edited: Aug 12, 2024 at 10:25 PM
8 6tammy_FL, Dr.LipidDallas, alex_tucson and 5 others
Reply Quote Save Share Report
15678911

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register